MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
38.50
-0.03 (-0.08%)
Jul 9, 2026, 11:06 AM EDT - Market open
MapLight Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Maintains $45 | Buy | Maintains | $45 | +16.88% | Jul 2, 2026 |
| Raymond James | Raymond James | Buy Initiates $46 | Buy | Initiates | $46 | +19.48% | Jun 24, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains $43 → $40 | Buy | Maintains | $43 → $40 | +3.90% | Jun 23, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $34 | Buy | Reiterates | $34 | -11.69% | Jun 23, 2026 |
| Needham | Needham | Buy Reiterates $37 → $42 | Buy | Reiterates | $37 → $42 | +9.09% | Jun 22, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $45 | Buy | Reiterates | $45 | +16.88% | Jun 22, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $28 → $36 | Buy | Reiterates | $28 → $36 | -6.49% | Jun 2, 2026 |
| UBS | UBS | Buy Initiates $48 | Buy | Initiates | $48 | +24.68% | May 26, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.